Clinical phenotypes and natural progression for motor neuron disease: Analysis from an Australian database

Amyotrophic Lateral Sclerosis

Volumn 10, Issue 2, 2009, Pages 79-84

  Talman, Paul ^a   Forbes, Andrew ^b   Mathers, Susan ^a  

^a Bethlehem Hospital   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Amyotrophic lateral sclerosis; Clinical database; Clinical patterns; Motor neuron disease

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUSTRALIA; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOTOR NEURON DISEASE; PRIMARY LATERAL SCLEROSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; SYMPTOMATOLOGY;

AGE OF ONSET; AMYOTROPHIC LATERAL SCLEROSIS; AUSTRALIA; DATABASES, FACTUAL; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PHENOTYPE; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 62549120838     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/17482960802195871     Document Type: Article

References (23)

1. Anonymous (1992) The Scottish Motor Neuron Disease Register: A prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989. Journal of Neurology, Neurosurgery & Psychiatry, 55, pp. 536-541.
2. Kasarkis, EJ, Dominic, K. and Oddone, EZ. (2004) The National Registry of Veterans with Amyotrophic Lateral Sclerosis: Department of Veterans Affairs Cooperative Studies Program (CSP) 500a. Amyotroph Lateral Scler Other Motor Neuron Disord., 5, pp. 129-132.
3. Miller, RG, Anderson Jr, FA, Bradley, WG, Brooks, BR, Mitsumoto, H. Munsat, TL et al. (2000) The ALS patient care database: Goals, design, and early results. ALS C.A.R.E. Study Group. Neurology., 54, pp. 53-57.
4. Millul, A., Beghi, E., Logroscino, G., Micheli, A., Vitelli, E. and Zardi, A. (2005) Survival of patients with amyotrophic lateral sclerosis in a population-based registry. Neuroepidemiology., 25, pp. 114-119.
5. Traynor, BJ, Codd, MB, Corr, B., Forde, C., Frost, E. and Hardiman, O. (1999) Incidence and prevalence of ALS in Ireland, 1995-1997: A population-based study. Neurology, 52, pp. 504-509.
6. Anonymous (1995) World Federation of Neurology Research Group on Neuromuscular Diseases Subcommittee on Motor Neuron Disease. Airlie House guidelines. Therapeutic trials in amyotrophic lateral sclerosis. Airlie House 'Therapeutic Trials in ALS' Workshop Contributors. Journal of the Neurological Sciences, 129, pp. 1-10.
7. Brooks, BR. (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial'Clinical limits of amyotrophic lateral sclerosis' workshop contributors (see comment). Journal of the Neurological Sciences, 124, pp. 96-107.
8. Miller, RG, Munsat, TL, Swash, M. and Brooks, BR. (1999) Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology Committee on Research. Journal of the Neurological Sciences., 169, pp. 2-12.
9. Haverkamp, LJ, Appel, V. and Appel, SH. (1995) Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain., 118, pp. 707-719.
10. Appel, V., Stewart, SS, Smith, G. and Appel, SH. (1987) A rating scale for amyotrophic lateral sclerosis: Description and preliminary experience. Annals of Neurology., 22, pp. 328-333.
11. Talman, P., Reid, C. and Mathers, S.
12. Gordon, PH, Cheng, B., Katz, IB, Pinto, M., Hays, AP Mitsumoto, H. et al. (2006) The natural history of primary lateral sclerosis (see comment). Neurology., 66, pp. 647-653.
13. Pringle, CE, Hudson, AJ, Munoz, DG, Kiernan, JA, Brown, WF and Ebers, GC. (1992) Primary lateral sclerosis: Clinical features, neuropathology and diagnostic criteria. Brain., 115, pp. 495-520.
14. Singer, MA, Statland, JM, Wolfe, GI and Barohn, RJ. (2007) Primary lateral sclerosis. Muscle & Nerve., 35, pp. 291-302.
15. Singer, J. and Willett, J. (2003) Applied Longitudinal Data Analysis: Modelling Change and Event Occurrence, Oxford University Press, New York
16. Collett, D. (2003) Modelling Survival Data in Medical Research, Chapman and Hall, London
17. Brooks, BR, Miller, RG, Swash, M., Munsat, TL and World Federation of Neurology Research Group on Motor Neuron D (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord., 1, pp. 293-299.
18. Leigh, PN, Swash, M., Iwasaki, Y., Ludolph, A., Meininger, V. Miller, RG et al. (2004) Amyotrophic lateral sclerosis: A consensus viewpoint on designing and implementing a clinical trial. Amyotrophic Lateral Scler Other Motor Neuron Disord., 5, pp. 84-98.
19. Eisen, A. and Weber, M. (2001) The motor cortex and amyotrophic lateral sclerosis. Muscle & Nerve., 24, pp. 564-573.
20. Ravits, J., Laurie, P., Fan, Y. and Moore, DH. (2007) Implications of ALS focality: Rostral-caudal distribution of lower motor neuron loss post mortem. Neurology., 68, pp. 1576-1582.
21. Ravits, J., Paul, P. and Jorg, C. (2007) Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology., 68, pp. 1571-1575.
22. Rosenfeld, J. and Swash, M. (2006) What's in a name? Lumping or splitting ALS, PLS, PMA, and the other motor neuron diseases (comment). Neurology., 66, pp. 624-625.
23. Shaw, PJ. (2005) Molecular and cellular pathways of neurodegeneration in motor neuron disease. Journal of Neurology. Neurosurgery & Psychiatry., 76, pp. 1046-1057.